Searched for
INDIAN PHARMA
Anupam Rasayan eyes US, Europe pharma push after Bliss deal, one-third revenue from drugsAnupam Rasayan India Ltd anticipates significant growth in its pharmaceutical segment over the next three years. The company expects pharma...- Indian SME pharma firms see shift of orders from China; cost, quality concerns remainSmall and mid-sized Indian pharmaceutical firms are witnessing a shift in orders away from China. As Western buyers diversify their supply ...
- Bank stocks lift Indian markets as crude prices ease, RBI decision eyedThe Indian stock markets saw an upswing fueled by the performance of banking stocks amid falling oil prices. The Sensex and Nifty enjoyed s...
- Market wrap: Trent, BSE, Coal India, Tech Mahindra top gainers and losers on Nifty and Sensex on TuesdayFranklin India Small Cap Fund crossed Rs 14,000 crore in AUM, while a Rs 10,000 monthly SIP grew to nearly Rs 1.94 crore over 20 years. The...
- Indices snap four-day losing streak as oil prices ease, positive global cuesIndian equity benchmarks recovered in Monday's session, breaking a four-day losing streak and reflecting positive global trends. The Sensex...
- Centre may seek legal view on licensing of sterile drugsThe government is actively exploring a proposal to expand central licensing authority over all sterile drug products following a recent Sup...
- Indian companies must invest in R&D, move from generics to innovation-led industry: Pharma leadersIndian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They high...
- Market wrap: ITC, BSE, HCL Tech, Asian Paints top gainers and losers on Nifty and Sensex on MondayIndian equity markets rebounded on Monday, with the Nifty and Sensex rising 0.60% and 0.66%, respectively. ITC led the gainers, while HCL T...
- AMFI reshuffle: NSE may get largecap status, SBI Fund Management may become midcap in H1 CY27Nuvama expects NSE to enter the largecap category and SBI Funds Management to become a midcap in AMFI’s H1 CY27 reshuffle. Bosch, Siemens E...
- Nifty rebound in sight after record 8-week losing streak: AnalystsNifty has dipped significantly, nearing a critical support range of 22,000 to 22,600, catching the attention of traders looking for a poten...
- Stocks in news: HDFC Bank, Infosys, Yes Bank, Hindustan Zinc and RVNLIndian equities continued their downward trend due to rising global bond yields and high crude oil prices. The Nifty 50 fell by 198.50 poin...
- Russia has agreed to take around 70K Indian skilled workers this year: Govt tells parliamentary panelExternal Affairs Minister S Jaishankar briefed a parliamentary panel on India’s multifaceted ties with Russia, including plans to expand tr...
- Carlsberg India unit, 3 other firms get Sebi nod to proceed with IPO plansSebi has provided observations for the IPOs of Carlsberg India, Matangi Rubber, Ujin Pharma, and TMC Transformer. Carlsberg's filing is und...
- Danish brewing giant Carlsberg’s India arm, 3 others get Sebi nod to float IPOsIn a significant move for India's market, Sebi has greenlit IPOs for Carlsberg's local entity, TMC Transformers, Ujin Pharma, and Matangi R...
- Carlsberg India IPO gets Sebi approval along with three other public offers. Check detailsIndia’s IPO pipeline expands as Sebi clears papers for Carlsberg India, Matangi Rubber, Ujin Pharma and TMC Transformer. The approvals come...
- From Jab to Pills: Novo Nordisk, Eli Lilly set to take obesity drug battle to IndiaIndia’s obesity drug market is set for a new phase as Novo Nordisk’s oral Wegovy and Eli Lilly’s oral GLP-1 orforglipron are expected to la...
- Globalisation 2.0, can it be furrowed home?Indian corporations are making bold strides abroad, with Essar establishing a massive $15 billion steel complex in Iowa. Notable companies ...
- Sensex falls 49 points, Nifty ends below 22,650 as market continues to bleed. What lies ahead?The Indian stock market saw further declines as the Sensex dipped nearly 49 points while the Nifty sank around 96 points by session's end. ...
- Sun Pharma plans $1 billion local debt sale for loan takeout, sources saySun Pharma is planning to raise about Rs 10,000 crore through rupee-denominated bonds to partly refinance a bridge loan used for its Organo...
- Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speciality drugsIndian pharma stocks, including Sun Pharma and Aurobindo Pharma, are in focus after the US exempted India and 19 other countries from 100% ...
Load More
